140 related articles for article (PubMed ID: 34731500)
1. An open-label prospective study to assess short incubation time white LED light photodynamic therapy in the treatment of superficial basal cell carcinoma.
Hellen R; Dhonncha EN; Havelin A; Kavanagh A; Moriarty B; Collins P
Photodermatol Photoimmunol Photomed; 2022 Jul; 38(4):322-327. PubMed ID: 34731500
[TBL] [Abstract][Full Text] [Related]
2. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
[TBL] [Abstract][Full Text] [Related]
3. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
4. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
5. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
6. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
8. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Wiegell SR; Skødt V; Wulf HC
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
[TBL] [Abstract][Full Text] [Related]
9. Treatment of superficial basal cell carcinoma with 7.8% 5-aminolaevulinic acid nanoemulsion-based gel (BF-200 ALA) and photodynamic therapy: Results in clinical practice in a tertiary hospital.
Navarro-Triviño FJ; Ayén-Rodríguez Á; Llamas-Molina JM; Saenz-Guirado S; Ruiz-Villaverde R
Dermatol Ther; 2021 Jan; 34(1):e14558. PubMed ID: 33210436
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
van Delft LCJ; Nelemans PJ; Kessels JPHM; Kreukels H; Roozeboom MH; de Rooij MJM; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Dermatology; 2022; 238(6):1044-1049. PubMed ID: 35598594
[TBL] [Abstract][Full Text] [Related]
11. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.
Clark C; Bryden A; Dawe R; Moseley H; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2003 Jun; 19(3):134-41. PubMed ID: 12914598
[TBL] [Abstract][Full Text] [Related]
12. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
13. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
Caekelbergh K; Nikkels AF; Leroy B; Verhaeghe E; Lamotte M; Vincent R
J Drugs Dermatol; 2009 Nov; 8(11):992-6. PubMed ID: 19894366
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.
Zeitouni NC; Sunar U; Rohrbach DJ; Paquette AD; Bellnier DA; Shi Y; Wilding G; Foster TH; Henderson BW
Dermatol Surg; 2014 Dec; 40(12):1390-4. PubMed ID: 25393353
[TBL] [Abstract][Full Text] [Related]
17. Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Logan IT; Kulakov EL; Perrett CM
Dermatol Surg; 2020 Oct; 46(10):1272-1278. PubMed ID: 32011386
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
